Metsera
Manufacturing · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3 World Trade Ctr 175, New York City, Ne...Phone Number
(212) 784-6595Website
www.metsera.comRevenue
$26.4 MillionStock Symbol
MTSRIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Metsera
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape.Explore more
Metsera Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Metsera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Metsera has new funding data
Product Launch: Get notified when Metsera launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Metsera recently announced quarterly report
Check out if Metsera is spiking on competitors!
Check if Metsera has recently received funding, and reach out quickly before it becomes old news!
Click to see if Metsera had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Metsera, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Metsera
Recommended Actions
Reach out to Masked Content who joined Metsera as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Metsera is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Metsera is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Metsera.
Metsera financials insights
Gather financial insights about Metsera, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$290M
Series B
$215M
Most Recent Scoops
Left Company
Executive Move
Matthew Lang, Chief Legal Officer & Corproate Secretary, has recently left the organization and now serves as Chief Operating Officer & General Counsel for Structure Therapeutics.
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Person-Based
Person-Based
Metsera News & Media
Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market
Pfizer CEO Albert Bourla told Yahoo Finance that Pfizer has a "right to win" on the obesity drugs that have become a major market.Even Bigger Venture Bucks For Obesity Therapies As Metsera Sells For Up To $10B
Several companies with a focus on obesity and weight management have raised sizable venture funding in the past couple of years. We take a look at the bigger picture of where all that money is going.Jim Cramer Says “I Think Pfizer’s Very Smart to Buy Metsera”
Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer offered insights on. Cramer discussed the company’s acquisition of Metsera during the episode. He commented: “There’s room for more than one winner in this race for GLP-1 weight loss supremacy, but some of these winners are going to be bigger than others. This morning, the […]Pfizer clinches $10bn Metsera deal as Novo Nordisk retreats
Pfizer’s US antitrust law play appears to have won the day, with Metsera choosing the less risky offer.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Metsera
Sign Up For FreeTo access detailed company insights
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs... Read More
